HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norihiro Nishimoto Selected Research

tocilizumab (atlizumab)

1/2020Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.
1/2018Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).
3/2017Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining efficacy in biologics-naive patients with rheumatoid arthritis: The FIRST Bio study.
5/2015Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study.
5/2014Immune response to influenza vaccine and pneumococcal polysaccharide vaccine under IL-6 signal inhibition therapy with tocilizumab.
4/2014Longterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan.
1/2014Retreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) study.
1/2014Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study.
4/2013Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement.
4/2013Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Norihiro Nishimoto Research Topics

Disease

58Rheumatoid Arthritis
05/2019 - 01/2002
15Juvenile Arthritis (Juvenile Idiopathic Arthritis)
04/2014 - 08/2004
11Inflammation (Inflammations)
03/2015 - 01/2002
10Castleman Disease (Castleman's Disease)
05/2014 - 01/2002
10Crohn Disease (Crohn's Disease)
10/2008 - 04/2004
8Infections
02/2012 - 09/2007
7Arthritis (Polyarthritis)
03/2015 - 12/2002
7Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2013 - 05/2005
6Autoimmune Diseases (Autoimmune Disease)
05/2009 - 09/2002
5Neoplasms (Cancer)
07/2013 - 10/2004
4Rheumatic Diseases (Rheumatism)
04/2013 - 12/2006
4Adult-Onset Still's Disease
05/2011 - 05/2005
4Multiple Myeloma
08/2008 - 01/2002
3Takayasu Arteritis (Arteritis, Takayasu's)
01/2020 - 05/2009
3Immunoglobulin G4-Related Disease
06/2017 - 01/2012
3Fibrosis (Cirrhosis)
10/2014 - 04/2010
3Systemic Scleroderma (Systemic Sclerosis)
06/2012 - 05/2011
2Ankylosing Spondylitis
08/2022 - 04/2013
2Multi-centric Castleman's Disease
06/2017 - 06/2012
2Osteoporosis
12/2015 - 01/2008
2Synovitis
03/2015 - 12/2012
2Lung Injury
08/2012 - 04/2010
2Acute-Phase Reaction
05/2011 - 05/2008
2Mesothelioma
06/2010 - 09/2006
2Malignant Mesothelioma
06/2010 - 09/2006
2Proteinuria
09/2009 - 01/2005
2Hypercholesterolemia
09/2009 - 10/2005
2Asthma (Bronchial Asthma)
06/2007 - 02/2005
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
12/2006 - 05/2003
2Glomerulonephritis
01/2005 - 12/2002
1Non-Radiographic Axial Spondyloarthritis
08/2022
1Amyloidosis
09/2020
1Human Influenza (Influenza)
05/2014
1Acute Disease
01/2014
1Neoplasm Metastasis (Metastasis)
07/2013
1Breast Neoplasms (Breast Cancer)
07/2013
1Disease Progression
01/2013
1Lung Diseases (Lung Disease)
09/2012
1Pulmonary Edema
08/2012
1Chronic Hepatitis (Chronic Active Hepatitis)
06/2012
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
06/2012
1Chronic Kidney Failure (Chronic Renal Failure)
06/2012
1Pancreatic Neoplasms (Pancreatic Cancer)
06/2012

Drug/Important Bio-Agent (IBA)

53Interleukin-6 (Interleukin 6)IBA
09/2020 - 01/2002
38tocilizumab (atlizumab)FDA Link
01/2020 - 03/2005
18CytokinesIBA
12/2015 - 01/2002
14Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
01/2020 - 12/2002
9Monoclonal AntibodiesIBA
04/2014 - 12/2002
6Immunoglobulin G (IgG)IBA
09/2020 - 12/2002
6Antirheumatic Agents (DMARD)IBA
05/2019 - 09/2007
5Adrenal Cortex Hormones (Corticosteroids)IBA
06/2012 - 03/2005
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2012 - 06/2006
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2010 - 06/2003
3Biomarkers (Surrogate Marker)IBA
02/2011 - 10/2003
2Hemoglobins (Hemoglobin)IBA
09/2020 - 10/2005
2AlbuminsIBA
09/2020 - 10/2005
2SteroidsIBA
01/2020 - 01/2009
2Abatacept (Orencia)FDA Link
05/2019 - 11/2016
2Immunoglobulins (Immunoglobulin)IBA
06/2017 - 01/2012
2Interleukin-6 InhibitorsIBA
12/2015 - 10/2008
2InterleukinsIBA
03/2015 - 11/2006
2ChemokinesIBA
03/2015 - 01/2013
2LigandsIBA
03/2015 - 04/2013
2Interleukin-1 (Interleukin 1)IBA
01/2013 - 05/2006
2Infliximab (Remicade)FDA Link
12/2012 - 01/2009
2Eosine Yellowish-(YS) (Eosin)IBA
08/2012 - 04/2010
2DNA (Deoxyribonucleic Acid)IBA
06/2011 - 01/2010
2OsteopontinIBA
12/2009 - 10/2003
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2006 - 09/2006
1HLA Antigens (Human Leukocyte Antigens)IBA
08/2022
1Triglycerides (Triacylglycerol)IBA
09/2020
1C-Reactive ProteinIBA
09/2020
1CholesterolIBA
09/2020
1Fibrinogen (Factor I)FDA Link
09/2020
1Hormones (Hormone)IBA
12/2015
1OsteoprotegerinIBA
03/2015
1Therapeutic UsesIBA
03/2015
1Tartrate-Resistant Acid PhosphataseIBA
03/2015
1AutoantibodiesIBA
03/2015
1ArginaseIBA
10/2014
1Interleukin-10 (Interleukin 10)IBA
10/2014
1Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
05/2014
1Polysaccharides (Glycans)IBA
05/2014
1Influenza Vaccines (Influenza Vaccine)FDA Link
05/2014
1HLA-DRB1 Chains (HLA DRB1)IBA
07/2013
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
07/2013
1Janus KinasesIBA
07/2013
1Superoxide Dismutase-1IBA
01/2013
1Etanercept (Enbrel)FDA Link
12/2012
1Free RadicalsIBA
12/2012
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2012
1Peroxidase (Myeloperoxidase)IBA
06/2012
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2012
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
06/2012

Therapy/Procedure

21Therapeutics
05/2014 - 12/2002
1Arthroplasty
12/2017
1Retreatment
01/2014
1Biological Therapy
09/2012
1Remission Induction
06/2012
1Plasmapheresis
06/2012